Výsledky vyhledávání - Class, Caleb
- Zobrazuji výsledky 1 - 19 z 19
-
1
-
2
Demographic, clinical, and geographical factors associated with lack of receipt of physician recommended chemotherapy in women with breast cancer in Texas Autor Thomas, Parijatham S., Class, Caleb A., Gandhi, Tanmay R., Bambhroliya, Arvind, Do, Kim-Anh, Brewster, Abenaa M.
Vydáno 2019Text -
3
Activation of gene expression by detergent-like protein domains Autor Broyles, Bradley K., Gutierrez, Andrew T., Maris, Theodore P., Coil, Daniel A., Wagner, Thomas M., Wang, Xiao, Kihara, Daisuke, Class, Caleb A., Erkine, Alexandre M.
Vydáno 2021Text -
4
WISP1 is associated to advanced disease, EMT and an inflamed tumor microenvironment in multiple solid tumors Autor Gaudreau, Pierre-Olivier, Clairefond, Sylvie, Class, Caleb A., Boulay, Pierre-Luc, Chrobak, Pavel, Allard, Bertrand, Azzi, Feryel, Pommey, Sandra, Do, Kim-Anh, Saad, Fred, Trudel, Dominique, Young, Marian, Stagg, John
Vydáno 2019Text -
5
Aberrant DNA hydroxymethylation reshapes transcription factor binding in myeloid neoplasms Autor Li, Jia, Hong, Tingting, Wei, Yue, Guo, Lei, Lee, Minjung, Yang, Hui, Class, Caleb, Yang, Yaling, Wang, Xiaoqiong, He, Hua, Siwko, Stefan, You, M. James, Zhou, Yubin, Garcia-Manero, Guillermo, Huang, Yun
Vydáno 2022Text -
6
LILRB4 Expression in Chronic Myelomonocytic Leukemia and Myelodysplastic Syndrome Based on Response to Hypomethylating Agents Autor Chien, Kelly S., Class, Caleb A., Montalban-Bravo, Guillermo, Wei, Yue, Sasaki, Koji, Naqvi, Kiran, Ganan-Gomez, Irene, Yang, Hui, Soltysiak, Kelly A., Kanagal-Shamanna, Rashmi, Do, Kim-Anh, Kantarjian, Hagop M., Garcia-Manero, Guillermo
Vydáno 2020Text -
7
KDM6B overexpression activates innate immune signaling and impairs hematopoiesis in mice Autor Wei, Yue, Zheng, Hong, Bao, Naran, Jiang, Shan, Bueso-Ramos, Carlos E., Khoury, Joseph, Class, Caleb, Lu, Yue, Lin, Kevin, Yang, Hui, Ganan-Gomez, Irene, Starczynowski, Daniel T., Do, Kim-Anh, Colla, Simona, Garcia-Manero, Guillermo
Vydáno 2018Text -
8
Th17 cells contribute to combination MEK inhibitor and anti-PD-L1 therapy resistance in KRAS/p53 mutant lung cancers Autor Peng, David H., Rodriguez, B. Leticia, Diao, Lixia, Gaudreau, Pierre-Olivier, Padhye, Aparna, Konen, Jessica M., Ochieng, Joshua K., Class, Caleb A., Fradette, Jared J., Gibson, Laura, Chen, Limo, Wang, Jing, Byers, Lauren A., Gibbons, Don. L.
Vydáno 2021Text -
9
Transcriptomic analysis implicates necroptosis in disease progression and prognosis in myelodysplastic syndromes Autor Montalban-Bravo, Guillermo, Class, Caleb A., Ganan-Gomez, Irene, Kanagal-Shamanna, Rashmi, Sasaki, Koji, Richard-Carpentier, Guillaume, Naqvi, Kiran, Wei, Yue, Yang, Hui, Soltysiak, Kelly A., Chien, Kelly, Bueso-Ramos, Carlos, Do, Kim-Anh, Kantarjian, Hagop, Garcia-Manero, Guillermo
Vydáno 2019Text -
10
The microRNA-183/96/182 cluster inhibits lung cancer progression and metastasis by inducing an interleukin-2-mediated antitumor CD8(+) cytotoxic T-cell response Autor Kundu, Samrat T., Rodriguez, B. Leticia, Gibson, Laura A., Warner, Amanda N., Perez, Mabel G., Bajaj, Rakhee, Fradette, Jared J., Class, Caleb A., Solis, Luisa M., Rojas Alvarez, Frank R., Wistuba, Ignacio I., Diao, Lixia, Chen, Fengju, Sachdeva, Mohit, Wang, Jing, Kirsch, David G., Creighton, Chad J., Gibbons, Don L.
Vydáno 2022Text -
11
Genomic context and TP53 allele frequency define clinical outcomes in TP53-mutated myelodysplastic syndromes Autor Montalban-Bravo, Guillermo, Kanagal-Shamanna, Rashmi, Benton, Christopher B., Class, Caleb A., Chien, Kelly S., Sasaki, Koji, Naqvi, Kiran, Alvarado, Yesid, Kadia, Tapan M., Ravandi, Farhad, Daver, Naval, Takahashi, Koichi, Jabbour, Elias, Borthakur, Gautham, Pemmaraju, Naveen, Konopleva, Marina, Soltysiak, Kelly A., Pierce, Sherry R., Bueso-Ramos, Carlos E., Patel, Keyur P., Kantarjian, Hagop, Garcia-Manero, Guillermo
Vydáno 2020Text -
12
Hematopoiesis under telomere attrition at the single-cell resolution Autor Thongon, Natthakan, Ma, Feiyang, Santoni, Andrea, Marchesini, Matteo, Fiorini, Elena, Rose, Ashley, Adema, Vera, Ganan-Gomez, Irene, Groarke, Emma M., Gutierrez-Rodrigues, Fernanda, Chen, Shuaitong, Lockyer, Pamela, Schneider, Sarah, Bueso-Ramos, Carlos, Montalban-Bravo, Guillermo, Class, Caleb A., Soltysiak, Kelly A., Pellegrini, Matteo, Sahin, Ergun, Bertuch, Alison A., DiNardo, Courtney D., Garcia-Manero, Guillermo, Young, Neal S., Dwyer, Karen, Colla, Simona
Vydáno 2021Text -
13
Oxidative Phosphorylation Is a Metabolic Vulnerability in Chemotherapy-Resistant Triple-Negative Breast Cancer Autor Evans, Kurt W., Yuca, Erkan, Scott, Stephen S., Zhao, Ming, Paez Arango, Natalia, Cruz Pico, Christian X., Saridogan, Turcin, Shariati, Maryam, Class, Caleb A., Bristow, Christopher A., Vellano, Christopher P., Zheng, Xiaofeng, Gonzalez-Angulo, Ana Maria, Su, Xiaoping, Tapia, Coya, Chen, Ken, Akcakanat, Argun, Lim, Bora, Tripathy, Debu, Yap, Timothy A., Francesco, Maria Emilia Di, Draetta, Giulio F., Jones, Philip, Heffernan, Timothy P., Marszalek, Joseph R., Meric-Bernstam, Funda
Vydáno 2021Text -
14
Evolutionary action score identifies a subset of TP53 mutated myelodysplastic syndrome with favorable prognosis Autor Kanagal-Shamanna, Rashmi, Montalban-Bravo, Guillermo, Katsonis, Panagiotis, Sasaki, Koji, Class, Caleb A., Jabbour, Elias, Sallman, David, Hunter, Anthony Michael, Benton, Christopher, Chien, Kelly S., Luthra, Rajyalakshmi, Bueso-Ramos, Carlos E., Kadia, Tapan, Andreeff, Michael, Komrokji, Rami S., Al Ali, Najla H, Short, Nicholas, Daver, Naval, Routbort, Mark J., Khoury, Joseph D., Patel, Keyur, Ganan-Gomez, Irene, Wei, Yue, Borthakur, Gautam, Ravandi, Farhad, Do, Kim-Anh, Soltysiak, Kelly A., Lichtarge, Olivier, Medeiros, L. Jeffrey, Kantarjian, Hagop, Garcia-Manero, Guillermo
Vydáno 2021Text -
15
Short-term treatment with multi-drug regimens combining BRAF/MEK-targeted therapy and immunotherapy results in durable responses in Braf-mutated melanoma Autor White, Michael G., Szczepaniak Sloane, Robert, Witt, Russell G., Reuben, Alexandre, Gaudreau, Pierre Olivier, Andrews, Miles C., Feng, Ningping, Johnson, Sarah, Class, Caleb A., Bristow, Christopher, Wani, Khalida, Hudgens, Courtney, Nezi, Luigi, Manzo, Teresa, De Macedo, Mariana Pettaccia, Hu, Jianhua, Davis, Richard, Jiang, Hong, Prieto, Peter, Burton, Elizabeth, Hwu, Patrick, Tawbi, Hussein, Gershenwald, Jeffrey, Lazar, Alexander J., Tetzlaff, Michael T., Overwijk, Willem, Woodman, Scott E, Cooper, Zachary A., Marszalek, Joseph R., Davies, Michael A., Heffernan, Timothy P., Wargo, Jennifer A.
Vydáno 2021Text -
16
Stem cell architecture drives myelodysplastic syndrome progression and predicts response to venetoclax-based therapy Autor Ganan-Gomez, Irene, Yang, Hui, Ma, Feiyang, Montalban-Bravo, Guillermo, Thongon, Natthakan, Marchica, Valentina, Richard-Carpentier, Guillaume, Chien, Kelly, Manyam, Ganiraju, Wang, Feng, Alfonso, Ana, Chen, Shuaitong, Class, Caleb, Kanagal-Shamanna, Rashmi, Ingram, Justin P., Ogoti, Yamini, Rose, Ashley, Loghavi, Sanam, Lockyer, Pamela, Cambo, Benedetta, Muftuoglu, Muharrem, Schneider, Sarah, Adema, Vera, McLellan, Michael, Garza, John, Marchesini, Matteo, Giuliani, Nicola, Pellegrini, Matteo, Wang, Jing, Walker, Jason, Li, Ziyi, Takahashi, Koichi, Leverson, Joel D., Bueso-Ramos, Carlos, Andreeff, Michael, Clise-Dwyer, Karen, Garcia-Manero, Guillermo, Colla, Simona
Vydáno 2022Text -
17
Author Correction: Stem cell architecture drives myelodysplastic syndrome progression and predicts response to venetoclax-based therapy Autor Ganan-Gomez, Irene, Yang, Hui, Ma, Feiyang, Montalban-Bravo, Guillermo, Thongon, Natthakan, Marchica, Valentina, Richard-Carpentier, Guillaume, Chien, Kelly, Manyam, Ganiraju, Wang, Feng, Alfonso, Ana, Chen, Shuaitong, Class, Caleb, Kanagal-Shamanna, Rashmi, Ingram, Justin P., Ogoti, Yamini, Rose, Ashley, Loghavi, Sanam, Lockyer, Pamela, Cambo, Benedetta, Muftuoglu, Muharrem, Schneider, Sarah, Adema, Vera, McLellan, Michael, Garza, John, Marchesini, Matteo, Giuliani, Nicola, Pellegrini, Matteo, Wang, Jing, Walker, Jason, Li, Ziyi, Takahashi, Koichi, Leverson, Joel D., Bueso-Ramos, Carlos, Andreeff, Michael, Clise-Dwyer, Karen, Garcia-Manero, Guillermo, Colla, Simona
Vydáno 2022Text -
18
CD38-mediated immunosuppression as a mechanism of tumor cell escape from PD-1/PD-L1 blockade Autor Chen, Limo, Diao, Lixia, Yang, Yongbin, Yi, Xiaohui, Leticia Rodriguez, B., Li, Yanli, Villalobos, Pamela A., Cascone, Tina, Liu, Xi, Tan, Lin, Lorenzi, Philip L., Huang, Anfei, Zhao, Qiang, Peng, Di, Fradette, Jared J., Peng, David H., Ungewiss, Christin, Roybal, Jonathon, Tong, Pan, Oba, Junna, Skoulidis, Ferdinandos, Peng, Weiyi, Carter, Brett W., Gay, Carl M., Fan, Youhong, Class, Caleb A., Zhu, Jingfen, Rodriguez-Canales, Jaime, Kawakami, Masanori, Averett Byers, Lauren, Woodman, Scott E., Papadimitrakopoulou, Vassiliki A., Dmitrovsky, Ethan, Wang, Jing, Ullrich, Stephen E., Wistuba, Ignacio I., Heymach, John V., Xiao-Feng Qin, F., Gibbons, Don L.
Vydáno 2018Text -
19
PRMT1-dependent regulation of RNA metabolism and DNA damage response sustains pancreatic ductal adenocarcinoma Autor Giuliani, Virginia, Miller, Meredith A., Liu, Chiu-Yi, Hartono, Stella R., Class, Caleb A., Bristow, Christopher A., Suzuki, Erika, Sanz, Lionel A., Gao, Guang, Gay, Jason P., Feng, Ningping, Rose, Johnathon L., Tomihara, Hideo, Daniele, Joseph R., Peoples, Michael D., Bardenhagen, Jennifer P., Geck Do, Mary K., Chang, Qing E., Vangamudi, Bhavatarini, Vellano, Christopher, Ying, Haoqiang, Deem, Angela K., Do, Kim-Anh, Genovese, Giannicola, Marszalek, Joseph R., Kovacs, Jeffrey J., Kim, Michael, Fleming, Jason B., Guccione, Ernesto, Viale, Andrea, Maitra, Anirban, Emilia Di Francesco, M., Yap, Timothy A., Jones, Philip, Draetta, Giulio, Carugo, Alessandro, Chedin, Frederic, Heffernan, Timothy P.
Vydáno 2021Text